Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Implant Sciences Corp (OTCQB:IMSC)

0.75
Delayed Data
As of Aug 28
 +0.0009 / +0.12%
Today’s Change
0.64
Today|||52-Week Range
1.82
-30.56%
Year-to-Date
SECTOR
Electronic Technology
INDUSTRY
Electronic Equipment/Instruments
MARKET CAP
$55.7M

Company Description

mplant Sciences Corp. designs, manufactures, and sells explosives trace detection (ETD) and drugs trace detection solutions for multiple security applications including aviation, transportation, customs, air cargo, critical infrastructure protection, ports and borders, force protection, public safety and emergency responders. Its products include Quantum Sniffer QS-H150 portable explosives detector for the simultaneous detection of explosives particulates and vapors with or without physical contact and in real-time and Quantum Sniffer QS-B220 desktop explosives and narcotics detector for the detection and identification of various military, commercial and improvised explosives, as well as narcotics. The company was founded in August 1984 and is headquartered in Wilmington, MA.

Contact Information

Implant Sciences Corp.
500 Research Drive
Wilmington Massachusetts 01887-4437
P:(978) 752-1700
Investor Relations:
19787521700116

Employees

Shareholders

Individual stakeholders5.24%
Mutual fund holders--
Other institutional--

Top Executives

William J. McGannPresident, Chief Executive Officer, COO & Director
Roger P. DeschenesChief Financial Officer & Vice President
Todd A. SilvestriVice President-Technology & Product Development
Brenda L. BaronVice President-Manufacturing & Technical Services
Robert P. LiscouskiDirector & Executive VP-Business Development